Activity and research directory

This project aims to employ novel approaches to discover new-generation polymyxin antibiotics targeting the deadly Gram-negative ‘superbugs’. Novel lead molecules have been licensed to Qpex Biopharma (US) for IND-enabling evaluations with a Phase-I study aimed at 2020.

This project uses knowledge recently gained about how gonorrhoea bacteria cause disease to develop new treatments that better control infections.

Expert veterinarians have published guidelines (for Australian pig veterinarians) on prescribing antimicrobials for use in pigs. The guidelines have been developed specifically for Australian conditions and reference the most contemporary knowledge available on AMR.

This research project will develop new technologies that will overcome the limitation of micro and nanotechnologies to small areas and flat surfaces.